People channel feed – Endpoints News

People channel feed

After winding down Quench Bio with a bold dose of honesty, Sam Truex finds 'perfect fit' at Atlas Venture

5 years ago

Ahead of Nasdaq debut, Saurabh Saha pads out the C-suite at Centessa, hiring a top Daiichi Sankyo alum as CMO

5 years ago

Perceptive's $310M US/China play woos new CEO from Eli Lilly's top-speed bamlanivimab team

5 years ago

Q&A: Aindrea Campbell goes small, stepping away from Apple to head manufacturing at Zymergen — where ambitions are big

5 years ago

2seventy: Nick Leschly brings a trio of top execs with him on top-speed flight from the bluebird nest

5 years ago

Is that another IPO in the making? Ex-Novartis CEO Joe Jimenez and a lead Kite player take up new posts at an off-the-shelf rival to 2 pioneering drugs

5 years ago

'Changing the whole game of drug discovery': Legendary R&D vet Roger Perlmutter leaps back into work as a biotech CEO

5 years ago

Lonnie Moulder woos a seasoned development expert from Hillhouse's US/China play to helm his startup

5 years ago

Stealthy Third Rock startup poaches oncology exec from Novartis — just days after his boss jumped ship

5 years ago

Alkermes hands a board seat to Alex Denner's Sarissa after facing renewed proxy pressure to 'refresh' directors

5 years ago

Bobbing on a sea of crises, bluebird's Nick Leschly sees his pay cut in half as the biotech prepares to split

5 years ago

Stanley Erck bagged $48M in pay as he guided Novavax on a remarkable turnaround in the hunt for a Covid-19 vaccine

5 years ago

Biogen's Michel Vounatsos takes home $18.7M in pay as the company battles to take aducanumab to market

5 years ago

Regeneron's Len Schleifer, George Yancopoulos start their ambitious 5-year plan, earning a front-loaded $270M combined

5 years ago

Exclusive: Ultimate biotech insider Dan Lynch takes his 30 years of experience to GV to fill a newly-created post

5 years ago

Early Zymergen investor Jenny Rooke reflects on 'chimeras' in biotech, what it takes to spot a $500M gem

5 years ago

Teva CEO Kåre Schultz sees a 35% raise despite the company's continued legal woes

5 years ago

Exclusive: Genentech's former Tecentriq 'CEO' jumps ship to head up commercial at an oncolytic virus player

5 years ago

MIT’s fabled billionaire scientist Robert Langer is stepping in to offer a key assist to Ovid CEO Jeremy Levin

5 years ago

Jami Rubin, once fabled for grilling biopharma execs, decamps to head finance at drug pricing disrupter

5 years ago

The doctor is in: Trump insider Ben Carson joins NASH player Galectin as a 'special consultant,' part-time spokesman

5 years ago

Eli Lilly-partnered biotech taps star investigator Alan List as CMO — a year after he resigned from Moffitt over China scandal

5 years ago

GlaxoSmithKline’s head of vaccine R&D is jumping to a wellness company concentrating on the microbiome as reports of an exodus start to spread

5 years ago

Eli Lilly axes 163 Dermira staffers, shutters Menlo Park site as it closes in around Dupixent rival lebrikizumab

5 years ago

First page Previous page 57 58 596061 62 63 Next page Last page